Post-launch
Diagnostic Pathway Variation: Why Delivery Breaks Before Discovery
Identifying Barriers to Biomarker Testing Efficiency: 100 Laboratories Mapped in 3 Months
Accelerating HCP Engagement in Myeloid Malignancies Through Real-world Data and Targeted Engagement
All resources
AnalyticsIQ and Diaceutics Partner to Launch Breakthrough Healthcare Audience Targeting
Diaceutics x Doceree Partnership: Power Precision HCP Targeting with Real-Time Diagnostic and Genomic Data
Diaceutics and Throtle Announce Strategic Collaboration to Enhance Healthcare Data Enrichment
Diaceutics and IQM Redefine HCP Marketing with Real-Time, AI-Powered Diagnostic Audiences
Join us at CAP26
Our team will be in Las Vegas from 3-6 October for CAP26.
5 key highlights from Fierce Pharma Week 2026
Explore 5 key highlights from Fierce Pharma Week 2026, including timely HCP engagement, commercial applications of AI, omnichannel pharma marketing and patient engagement.
Precision for All: Watch the New Diaceutics Manifesto
Diaceutics empowers biopharma to enhance patient outcomes by providing data-driven solutions for diagnostic-driven therapies. Ensuring every eligible patient receives timely and effective treatment.
The Clinical Decision Making Window: How Timing Determines Therapy Uptake
Discover how timing influences therapy uptake in diagnostic-driven treatments and learn how targeted engagement can enhance patient outcomes within the clinical decision-making window.
HCP Engagement Strategies: 4 Takeaways from Fierce Pharma 2026
Discover key insights from Fierce Pharma Engage 2026 on evolving HCP engagement strategies, emphasizing AI, content relevance, and outcome-based performance measurement for impactful interactions.
From Blockbusters to Biomarkers: Rethinking Commercialization for the Precision Era and the Importance of Diagnostic Testing
Discover how Targeted Commercialization transforms precision medicine by aligning diagnostic testing with therapy launches, ensuring the right patients receive timely treatments.
Data-driven targeting in HCP education: Engaging physicians within the critical treatment decision
Engage healthcare professionals effectively with data-driven strategies that enhance treatment decisions and improve patient outcomes in this informative online webinar.
Delivering precision medicine success through a multi-year commercialization partnership
Discover how a global pharmaceutical leader successfully launched a first-in-class oncology therapy through strategic partnerships, accelerating testing readiness and driving adoption in precision medicine.
ESMO 2025: Top 5 Key Cancer Diagnostics Takeaways From Our Experts
Discover 5 key insights from ESMO 2025 on cancer diagnostics, focusing on ctDNA, antibody-drug conjugates, and innovative strategies for improving patient outcomes in precision medicine.
Identifying Barriers to Biomarker Testing Efficiency: 100 Laboratories Mapped in 3 Months
Diaceutics enhances biomarker testing efficiency, engaging over 150 labs to identify workflow barriers, optimize practices, and support timely clinical decision-making for better patient outcomes.
Redefining HCP Engagement with Clinical, Behavioral & Companion Diagnostics
Transform HCP engagement by integrating clinical, behavioral, and companion diagnostics data for precise targeting and improved outreach effectiveness. Discover the future of pharma marketing.
Amplifying Your Precision Medicine Strategy: The role of Engagement Experts and Peer Networks
Enhance your precision medicine strategy through multi-modal communications and peer engagement, driving effective diagnostic commercialization and maximizing patient outcomes.